SIRT7 as a context-dependent biomarker and therapeutic target: Insights from a pan-cancer study
Fig 5
(A) SIRT7 expression levels (log2 TPM) across multiple cancer types, comparing tumor and normal tissues. * indicates significant expression, and *** means highly significant expression (Source: TIMER2.0). (B-I) Kaplan-Meier overall survival analyses depicting survival differences between high and low SIRT7 expression groups in (B) BLCA, (C) KIRC, (D) KIRP, (E) LGG, (F) LIHC, (G) PRAD, (H) SARC, and (I) UCEC (Source: GEPIA2).